We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.3B
AUM Growth
-$40.2M
(-0.25%)
Cap. Flow
-$420M
Cap. Flow
% of AUM
-2.59%
Top 10 Holdings %
Top 10 Hldgs %
42.17%
Holding
1,545
New
54
Increased
211
Reduced
408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$141M |
| 2 |
Chubb
CB
|
+$56.9M |
| 3 |
Apple
AAPL
|
+$39.9M |
| 4 |
Perrigo
PRGO
|
+$39.1M |
| 5 |
Service Corp International
SCI
|
+$30.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$150M |
| 2 |
CB
CHUBB CORPORATION
CB
|
+$110M |
| 3 |
American International
AIG
|
+$103M |
| 4 |
AGN
Allergan plc
AGN
|
+$96.4M |
| 5 |
CVS Health
CVS
|
+$45.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.67% |
| 2 | Healthcare | 15.11% |
| 3 | Industrials | 8.73% |
| 4 | Technology | 7.81% |
| 5 | Consumer Staples | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.06T
| $3.17B | 19.49% |
14,845
-73
| -0.5% | -$14.6M |
|
2
Brookfield
BN
$101B
| $610M | 3.75% |
49,940,816
+96,823
| +0.2% | +$1.04M |
|
3
Microsoft
MSFT
$2.83T
| $434M | 2.67% |
7,865,133
-345,266
| -4% | -$18.1M |
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.06T
| $381M | 2.34% |
2,685,899
+50,790
| +2% | +$6.73M |
|
|
5
CVS Health
CVS
$136B
| $319M | 1.96% |
3,070,825
-467,303
| -13% | -$45.4M |
|
6
AB InBev
BUD
$155B
| $312M | 1.92% |
2,499,020
+9,778
| +0.4% | +$1.16M |
|
|
7
Apple
AAPL
$4.72T
| $295M | 1.81% |
10,813,380
+1,601,892
| +17% | +$39.9M |
|
8
Johnson & Johnson
JNJ
$624B
| $293M | 1.8% |
2,705,568
-119,024
| -4% | -$12.3M |
|
9
Zimmer Biomet
ZBH
$17.3B
| $275M | 1.69% |
2,656,121
+116,319
| +5% | +$11.3M |
|
|
10
Perrigo
PRGO
$1.4B
| $264M | 1.62% |
2,061,362
+285,766
| +16% | +$39.1M |
|
11
Wells Fargo
WFC
$261B
| $250M | 1.54% |
5,169,416
-550,510
| -10% | -$27M |
|
|
12
Pfizer
PFE
$143B
| $247M | 1.52% |
8,785,789
+4,923,294
| +127% | +$141M |
|
13
Danaher
DHR
$135B
| $246M | 1.52% |
3,862,523
+290,677
| +8% | +$17.3M |
|
14
Honeywell
HON
$78B
| $229M | 1.41% |
2,278,501
-49,047
| -2% | -$4.6M |
|
15
Aramark
ARMK
$15B
| $219M | 1.35% |
9,144,896
-258,498
| -3% | -$5.93M |
|
16
H&R Block
HRB
$5.06B
| $206M | 1.27% |
7,790,366
+71,701
| +0.9% | +$2.25M |
|
17
Comcast
CMCSA
$78.3B
| $199M | 1.22% |
6,506,808
+728,916
| +13% | +$20.9M |
|
18
Oracle
ORCL
$346B
| $185M | 1.14% |
4,531,843
-250,209
| -5% | -$9.26M |
|
19
Philip Morris
PM
$298B
| $173M | 1.06% |
1,763,108
-8,048
| -0.5% | -$738K |
|
|
DISCK
20
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $163M | 1% |
6,021,347
-477,390
| -7% | -$12.4M |
|
21
Gilead Sciences
GILD
$162B
| $154M | 0.94% |
1,671,808
+127,631
| +8% | +$11.5M |
|
|
22
American International
AIG
$41.4B
| $140M | 0.86% |
2,597,073
-1,903,447
| -42% | -$103M |
|
23
Accenture
ACN
$84.9B
| $137M | 0.84% |
1,183,071
-9,180
| -0.8% | -$943K |
|
|
JAH
24
DELISTED
JARDEN CORPORATION
JAH
| $130M | 0.8% |
2,198,721
-14,119
| -0.6% | -$755K |
|
25
3M
MMM
$87.5B
| $127M | 0.78% |
910,777
-3,463
| -0.4% | -$445K |
|
Similar funds
SAM
First Manhattan's Q1 2016 Portfolio in Review
As of Q1 2016, First Manhattan held 1,545 positions worth $16.3B, down 0.25% from $16.3B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
First Manhattan's Q1 2016 filing shows 54 new, 211 increased, 408 reduced and 84 closed positions. Its largest new stake was GCP Applied Technologies Inc.: 600,612 shares worth $12M. The largest sale was RTX Corp, an estimated $150M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q1 2016 buy was GCP Applied Technologies Inc.: 600,612 shares worth $12M.
- First Manhattan added most to Pfizer in Q1 2016, an estimated $141M increase.
- First Manhattan's biggest Q1 2016 reduction was RTX Corp, cutting an estimated $150M.
- First Manhattan fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $110M.
- First Manhattan's ten largest holdings make up 42% of its $16.3B portfolio in Q1 2016.
- First Manhattan opened 54 new positions and closed 84 in Q1 2016.
- First Manhattan's portfolio value fell 0.25% quarter-over-quarter to $16.3B.
Based on First Manhattan's 13F filing for Q1 2016, filed 22 Apr 2016.